Estimated visceral adipose tissue, but not body mass index, is associated with reductions in glomerular filtration rate based on cystatin C in the early stages of chronic kidney disease

International Journal of Nephrology

Volumn 2014, Issue , 2014, Pages

  França, Ana Karina Teixeira Da Cunha ^a   Santos, Alcione Miranda Dos ^a   Salgado, João Victor ^a   Hortegal, Elane Viana ^a   Silva, Antônio Augusto Moura Da ^a   Salgado Filho, Natalino ^a  

^a FEDERAL UNIVERSITY OF MARANHÃO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84901813250     PISSN: 2090214X     EISSN: 20902158     Source Type: Journal    
DOI: 10.1155/2014/574267     Document Type: Article

References (39)

1. Levey A. S., Andreoli S. P., DuBose T., Provenzano R., Collins A. J., CKD: common, harmful, and treatable-world kidney day 2007. The American Journal of Kidney Diseases 2007 49 2 175 179 2-s2.0-33846619766 10.1053/j.ajkd.2006.12. 013 (Pubitemid 46172437)
2. Flegal K. M., Carroll M. D., Ogden C. L., Johnson C. L., Prevalence and trends in obesity among US adults, 1999-2000. Journal of the American Medical Association 2002 288 14 1723 1727 2-s2.0-0037048669
3. Poirier P., Giles T. D., Bray G. A., Hong Y., Stern J. S., Pi-Sunyer F. X., Eckel R. H., Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on obesity and heart disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006 113 6 898 918 2-s2.0-33644850953 10.1161/CIRCULATIONAHA.106. 171016
4. Friedman A. N., Strother M., Quinney S. K., Hall S., Perkins S. M., Brizendine E. J., Inman M., Gomez G., Shihabi Z., Moe S., Li L., Measuring the glomerular filtration rate in obese individuals without overt kidney disease. Nephron: Clinical Practice 2010 116 3 c224 c234 2-s2.0-77954192357 10.1159/000317203
5. Henegar J. R., Bigler S. A., Henegar L. K., Tyagi S. C., Hall J. E., Functional and structural changes in the kidney in the early stages of obesity. Journal of the American Society of Nephrology 2001 12 6 1211 1217 2-s2.0-0035017738 (Pubitemid 32472634)
6. Hsu C.-Y., McCulloch C. E., Iribarren C., Darbinian J., Go A. S., Body mass index and risk for end-stage renal disease. Annals of Internal Medicine 2006 144 1 21 28 2-s2.0-33644756801 (Pubitemid 46780716)
7. Ikizler T. A., Greene J. H., Wingard R. L., Parker R. A., Hakim R. M., Spontaneous dietary protein intake during progression of chronic renal failure. Journal of the American Society of Nephrology 1995 6 5 1386 1391 2-s2.0-0028866516
8. Noori N., Hosseinpanah F., Nasiri A. A., Azizi F., Comparison of overall obesity and abdominal adiposity in predicting chronic kidney disease incidence among adults. Journal of Renal Nutrition 2009 19 3 228 237 2-s2.0-64849113650 10.1053/j.jrn.2008.11.005
9. Vupputuri S., Fox C. S., Coresh J., Woodward M., Muntner P., Differential estimation of CKD using creatinine versus cystatin C-based estimating equations by category of body mass index. The American Journal of Kidney Diseases 2009 53 6 993 1001 2-s2.0-67349114859 10.1053/j.ajkd.2008.12.043
10. Elsayed E. F., Sarnak M. J., Tighiouart H., Griffith J. L., Kurth T., Salem D. N., Levey A. S., Weiner D. E., Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. The American Journal of Kidney Diseases 2008 52 1 29 38 2-s2.0-45449094187 10.1053/j.ajkd.2008.02.363 (Pubitemid 351853273)
11. Pou K. M., Massaro J. M., Hoffmann U., Vasan R. S., Maurovich-Horvat P., Larson M. G., Keaney J. F. Jr., Meigs J. B., Lipinska I., Kathiresan S., Murabito J. M., O'Donnell C. J., Benjamin E. J., Fox C. S., Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation 2007 116 11 1234 1241 2-s2.0-34948902196 10.1161/CIRCULATIONAHA.107.710509 (Pubitemid 47517534)
12. Fox C. S., Massaro J. M., Hoffmann U., Pou K. M., Maurovich-Horvat P., Liu C.-Y., Vasan R. S., Murabito J. M., Meigs J. B., Cupples L. A., D'Agostino R. B., O'Donnell C. J., Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the framingham heart study. Circulation 2007 116 1 39 48 2-s2.0-34347351228 10.1161/CIRCULATIONAHA. 106.675355 (Pubitemid 47016245)
13. Kim S. R., Yoo J. H., Song H. C., Lee S. S., Yoo S. J., Kim Y.-D., Lim Y. S., Kim H. W., Yang C. W., Kim Y.-S., Choi E. J., Kim Y. K., Relationship of visceral and subcutaneous adiposity with renal function in people with type 2 diabetes mellitus. Nephrology Dialysis Transplantation 2011 26 11 3550 3555 2-s2.0-80155192407 10.1093/ndt/gfq634
14. Young J. A., Hwang S.-J., Sarnak M. J., Hoffmann U., Massaro J. M., Levy D., Benjamin E. J., Larson M. G., Vasan R. S., O'Donnell C. J., Fox C. S., Association of visceral and subcutaneous adiposity with kidney function. Clinical Journal of the American Society of Nephrology 2008 3 6 1786 1791 2-s2.0-58149343649 10.2215/CJN.02490508
15. van der Kooy K., Leenen R., Seidell J. C., Deurenberg P., Droop A., Bakker C. J. G., Waist-hip ratio is a poor predictor of changes in visceral fat. The American Journal of Clinical Nutrition 1993 57 3 327 333 2-s2.0-0027509641 (Pubitemid 23083643)
16. Garaulet M., Hernández-Morante J. J., Tébar F. J., Zamora S., Canteras M., Two-dimensional predictive equation to classify visceral obesity in clinical practice. Obesity 2006 14 7 1181 1191 2-s2.0-33846866068 10.1038/oby.2006.135 (Pubitemid 46219684)
17. Bonora E., Micciolo R., Ghiatas A. A., Lancaster J. L., Alyassin A., Muggeo M., DeFronzo R. A., Is it possible to derive a reliable estimate of human visceral and subcutaneous abdominal adipose tissue from simple anthropometric measurements? Metabolism: Clinical and Experimental 1995 44 12 1617 1625 2-s2.0-0029553536 10.1016/0026-0495(95)90084-5 (Pubitemid 26102603)
18. Nagai M., Komiya H., Mori Y., Ohta T., Developments in estimating visceral fat area from medical examination data. Journal of Atherosclerosis and Thrombosis 2008 15 4 193 198 2-s2.0-56349112857
19. Buysschaert M., Joudi I., Wallemacq P., Hermans M. P., Comparative performance of serum cystatin-C versus serum creatinine in diabetic subjects. Diabetes and Metabolism 2003 29 4 377 383 2-s2.0-0141844559 (Pubitemid 37187105)
20. Filler G., Bökenkamp A., Hofmann W., Le Bricon T., Martínez-Brú C., Grubb A., Cystatin C as a marker of GFR: history, indications, and future research. Clinical Biochemistry 2005 38 1 1 8 2-s2.0-10644286723 10.1016/j.clinbiochem.2004.09.025 (Pubitemid 39647648)
21. Baxmann A. C., Ahmed M. S., Marques N. C., Menon V. B., Pereira A. B., Kirsztajn G. M., Heilberg I. P., Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. Clinical Journal of the American Society of Nephrology 2008 3 2 348 354 2-s2.0-42549091940 10.2215/CJN.02870707
22. Naour N., Fellahi S., Renucci J.-F., Poitou C., Rouault C., Basdevant A., Dutour A., Alessi M.-C., Bastard J.-P., Clément K., Guerre-Millo M., Potential contribution of adipose tissue to elevated serum cystatin C in human obesity. Obesity (Silver Spring) 2009 17 12 2121 2126 2-s2.0-72449178441 10.1038/oby.2009.96
23. Salgado J. V., Salgado B. J., Bariatric surgery-induced weight loss: does it have any impacto n serum cystatin C levels? Surgery for Obesity and Related Diseases 2013 1 10.1016/j.soard.2013.08.007
24. Levey A. S., Eckardt K.-U., Tsukamoto Y., Levin A., Coresh J., Rossert J., De Zeeuw D., Hostetter T. H., Lameire N., Eknoyan G., Willis K., Definition and classification of chronic kidney disease: a position statement from kidney disease: improving Global Outcomes (KDIGO). Kidney International 2005 67 6 2089 2100 2-s2.0-23044448585 10.1111/j.1523-1755.2005.00365.x (Pubitemid 41623371)
25. Larsson A., Malm J., Grubb A., Hansson L.-O., Calculation of glomerular filtration rate expressed in mL/min from plasma cystatin C values in mg/L. Scandinavian Journal of Clinical and Laboratory Investigation 2004 64 1 25 30 2-s2.0-1442290238 10.1080/00365510410003723 (Pubitemid 38283206)
26. Stevens L. A., Coresh J., Schmid C. H., Feldman H. I., Froissart M., Kusek J., Rossert J., Van Lente F., Bruce R. D. III, Zhang Y., Greene T., Levey A. S., Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. The American Journal of Kidney Diseases 2008 51 3 395 406 2-s2.0-39449112419 10.1053/j.ajkd.2007.11.018 (Pubitemid 351273480)
27. Stevens L. A., Coresh J., Greene T., Levey A. S., Assessing kidney function: measured and estimated glomerular filtration rate. The New England Journal of Medicine 2006 354 23 2473 2483 2-s2.0-33744958852 10.1056/NEJMra054415 (Pubitemid 43855050)
28. Salgado J. V., Neves F. A., Bastos M. G., França A. K., Brito D. J., Santos E. M., Salgado Filho N., Monitoring renal function: measured and estimated glomerular filtration rates: a review. Brazilian Journal of Medical and Biological Research 2010 43 6 528 536 2-s2.0-77953941516 10.1590/S0100-879X2010007500040
29. Salgado J. V., Salgado B. J., Neves F. A., Cystatin C may better reflect the effect of obesity on renal function. Obesity 2012 20 6 1136
30. Salgado J. V., Souza F. L., Salgado B. J., How to understand the association between cystatin C levels and cardiovascular disease: imbalance, counterbalance, or consequence? Journal of Cardiology 2013 62 6 331 335
31. Köttgen A., Selvin E., Stevens L. A., Levey A. S., van Lente F., Coresh J., Serum cystatin C in the United States: the third national health and nutrition examination survey (NHANES III). The American Journal of Kidney Diseases 2008 51 3 385 394 2-s2.0-39449136475 10.1053/j.ajkd.2007.11.019 (Pubitemid 351273481)
32. Muntner P., Winston J., Uribarri J., Mann D., Fox C. S., Overweight, obesity, and elevated serum cystatin C levels in adults in the United States. The American Journal of Medicine 2008 121 4 341 348 2-s2.0-41249101945 10.1016/j.amjmed.2008.01.003 (Pubitemid 351444785)
33. Schück O., Teplan V., Stollová M., Skibová J., Estimation of glomerular filtration rate in obese patients with chronic renal impairment based on serum cystatin C levels. Clinical Nephrology 2004 62 2 92 96 2-s2.0-4444249639 (Pubitemid 39162760)
34. Sledzinski T., Proczko-Markuszewska M., Kaska L., Stefaniak T., Swierczynski J., Serum cystatin C in relation to fat mass loss after bariatric surgery. Polski Przegla̧d Chirurgiczny 2012 84 4 202 207
35. Marwyne M. N., Loo C. Y., Halim A. G., Norella K., Sulaiman T., Zaleha M. I., Estimation of glomerular filtration rate using serum cystatin C in overweight and obese subjects. Medical Journal of Malaysia 2011 66 4 313 317 2-s2.0-83755225427
36. Pi-Sunyer F. X., The obesity epidemic: pathophysiology and consequences of obesity. Obesity Research 2002 10 supplement 2 97S 104S 2-s2.0-0042484813 (Pubitemid 41132563)
37. Hall J. E., Kuo J. J., da Silva A. A., de Paula R. B., Liu J., Tallam L., Obesity-associated hypertension and kidney disease. Current Opinion in Nephrology and Hypertension 2003 12 2 195 200 2-s2.0-0037335214 10.1097/00041552-200303000-00011 (Pubitemid 36288321)
38. Naumnik B., Myśliwiec M., Renal consequences of obesity. Medical Science Monitor 2010 16 8 RA163 RA170 2-s2.0-77956204990
39. Salgado J. V., Franca A. K., Cabral N. A., Cystatin C, kidney function, and cardiovascular risk factors in primary hypertension. Revista Da Associacao Medica Brasileira 2013 59 1 21 27